FI940657A - Uusia 4-oksosyklisiä ureoita, jotka ovat käyttökelpoisia sydämen rytmihäiriöiden ja värinän vastaisina aineina - Google Patents

Uusia 4-oksosyklisiä ureoita, jotka ovat käyttökelpoisia sydämen rytmihäiriöiden ja värinän vastaisina aineina Download PDF

Info

Publication number
FI940657A
FI940657A FI940657A FI940657A FI940657A FI 940657 A FI940657 A FI 940657A FI 940657 A FI940657 A FI 940657A FI 940657 A FI940657 A FI 940657A FI 940657 A FI940657 A FI 940657A
Authority
FI
Finland
Prior art keywords
nil
unsubstituted
saturated
substituted
alkyl
Prior art date
Application number
FI940657A
Other languages
English (en)
Swedish (sv)
Other versions
FI940657A0 (fi
FI109696B (fi
Inventor
Jr Stanford Salvatore Pelosi
Chia-Nien Yu
Mark Arthur Calcagno
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Publication of FI940657A0 publication Critical patent/FI940657A0/fi
Publication of FI940657A publication Critical patent/FI940657A/fi
Application granted granted Critical
Publication of FI109696B publication Critical patent/FI109696B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/80Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI940657A 1991-08-14 1994-02-11 Menetelmä sydämen rytmihäiriöiden ja värinän vastaisina aineina käyttökelpoisten 4-oksosyklisten ureayhdisteiden valmistamiseksi FI109696B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74486791A 1991-08-14 1991-08-14
US74486791 1991-08-14
PCT/US1992/006684 WO1993004061A1 (en) 1991-08-14 1992-08-10 Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
US9206684 1992-08-10

Publications (3)

Publication Number Publication Date
FI940657A0 FI940657A0 (fi) 1994-02-11
FI940657A true FI940657A (fi) 1994-02-11
FI109696B FI109696B (fi) 2002-09-30

Family

ID=24994275

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940657A FI109696B (fi) 1991-08-14 1994-02-11 Menetelmä sydämen rytmihäiriöiden ja värinän vastaisina aineina käyttökelpoisten 4-oksosyklisten ureayhdisteiden valmistamiseksi

Country Status (27)

Country Link
US (1) US5462940A (fi)
EP (2) EP1231208A3 (fi)
JP (1) JP3040473B2 (fi)
KR (2) KR100273605B1 (fi)
AT (1) ATE220675T1 (fi)
AU (1) AU668360B2 (fi)
BR (1) BR9206369A (fi)
CA (1) CA2115427C (fi)
CZ (1) CZ282368B6 (fi)
DE (1) DE69232681T2 (fi)
DK (1) DK0598061T3 (fi)
ES (1) ES2180537T3 (fi)
FI (1) FI109696B (fi)
HK (1) HK1048806A1 (fi)
HU (1) HU221317B1 (fi)
IL (1) IL102793A (fi)
MX (1) MX9204730A (fi)
MY (1) MY109205A (fi)
NO (5) NO306676B1 (fi)
NZ (1) NZ243938A (fi)
PH (1) PH31451A (fi)
PL (2) PL170984B1 (fi)
PT (1) PT100777B (fi)
RU (2) RU2221788C2 (fi)
SK (1) SK282656B6 (fi)
TW (1) TW232691B (fi)
WO (1) WO1993004061A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083945A (en) * 1995-06-07 2000-07-04 The Procter & Gamble Company Cyclic ureas useful as antiarrhythmic and antifibrillatory agents
AU6320998A (en) 1997-02-21 1998-09-09 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
US6048877A (en) * 1997-02-21 2000-04-11 Bristol-Myers Squibb Company Tetralone derivatives as antiarrhythmic agents
US6262068B1 (en) 1997-02-21 2001-07-17 Bristol-Myers Squibb Company Lactam derivatives as antiarrhythmic agents
US6664250B2 (en) 1998-01-20 2003-12-16 Bristol-Myers Squibb Co. Lactam derivatives as antiarrhythmic agents
US6413785B1 (en) 1998-02-20 2002-07-02 The Procter & Gamble Co. Solid phase synthesis of 1-aminohydantoins
BR9910074A (pt) * 1998-04-29 2000-12-26 Procter & Gamble Processo para fabricação de uréias 1,3-di-substituìdas-4-oxocìclicas
PL198951B1 (pl) * 1998-04-29 2008-08-29 Procter & Gamble Sposób wytwarzania 1,3-dipodstawionych-4-oksocyklicznych moczników
CN100443473C (zh) * 2005-04-30 2008-12-17 中国药科大学 1-氨基-3-(氮杂环基烷基)-2,4-咪唑二酮的合成方法
DE602006014186D1 (de) * 2005-10-18 2010-06-17 Seoul Nat Univ Ind Foundation Verfahren zur herstellung eines rekombinanten peptids aus spinnengift, und das peptid enthaltende analgetische zusammensetzung
TW200840578A (en) * 2006-12-15 2008-10-16 Procter & Gamble Compositions of azimilide dihydrochloride
US20120178762A1 (en) 2006-12-15 2012-07-12 Warner Chilcott Company, Llc Compositions of azimilide dihydrochloride
CN101735202B (zh) * 2009-12-17 2012-05-30 天津药物研究院 盐酸阿齐利特的晶型ⅰ及其制备方法和用途
CN101735205B (zh) * 2009-12-17 2013-05-15 天津药物研究院 盐酸阿齐利特的晶型ⅴ及其制备方法和用途
CN101735203B (zh) * 2009-12-17 2012-05-23 天津药物研究院 盐酸阿齐利特的晶型ⅱ及其制备方法和用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB939941A (en) * 1959-04-14 1963-10-16 Norwich Pharma Co Improvements in or relating to the manufacture of derivatives of 5-nitrofuran
US3182058A (en) * 1960-10-31 1965-05-04 Pfizer & Co C Nitrofuran derivatives
DE1202281B (de) * 1960-11-21 1965-10-07 Josef Klosa Dipl Chem Dr Verfahren zur Herstellung von N-(5-Nitro-2-furfuryliden)-1-aminohydantoinen
NL272958A (fi) * 1960-12-27
NL272960A (fi) * 1960-12-27
FR1310188A (fi) * 1960-12-27 1963-03-06
NL129329C (fi) * 1960-12-27 1900-01-01
DE1201845B (de) * 1962-07-14 1965-09-30 Zambon Spa Verfahren zur Herstellung von N-(5-Nitro-2-furfuryliden)-1-aminohydantoin
NL300307A (fi) * 1963-06-10
US3415821A (en) * 1965-09-07 1968-12-10 Norwich Pharma Co 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones
NL6900631A (fi) * 1968-01-26 1969-07-29
JPS5032271B2 (fi) * 1973-06-06 1975-10-18
US4001222A (en) * 1975-10-14 1977-01-04 Morton-Norwich Products, Inc. 3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4393204A (en) * 1982-05-21 1983-07-12 Norwich Eaton Pharmaceuticals, Inc. 3-[[5-(4-Chlorophenyl)furfurylidene]amino]-5-(substituted)-2-oxazolidinones
JPS5913780A (ja) * 1982-07-13 1984-01-24 Takeda Chem Ind Ltd フルオロウラシル誘導体および抗腫瘍剤
US4543359A (en) * 1982-10-01 1985-09-24 Eaton Laboratories, Inc. Treating cardiac arrhythmias with dantrolene sodium
FR2539412B1 (fr) * 1983-01-13 1986-02-21 Shoichiro Ozaki Derives du 5-fluoruracile et leurs utilisations therapeutiques en tant qu'agents carcinostatiques
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
US4720580A (en) * 1984-09-21 1988-01-19 American Home Products Corporation N-(aminoalkylene)benzenesulfonamides
US4713382A (en) * 1985-05-30 1987-12-15 Syntex (U.S.A.) Inc. N-phenyl-4-phenyl-1-piperazinecarboxamidines and related compounds as antiarrhythmic agents
US4707499A (en) * 1985-12-02 1987-11-17 G. D. Searle & Co. 3-alkyl-5-(substituted amino)methyl)dihydro-3-phenyl-2(3H)-furanones and imino analogs thereof used for treatment of arrhythmia
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
US4804662A (en) * 1987-05-05 1989-02-14 Schering A.G. Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents
US4851526A (en) * 1987-09-04 1989-07-25 Schering A.G. 1-(4-Substituted phenyl)-1H-imidazoles compounds
US4870095A (en) * 1988-06-13 1989-09-26 Sterling Drug, Inc. 1H-pyrazole-1-alkanamides, antiarrhythmic compositions and use
JPH0276882A (ja) * 1988-06-20 1990-03-16 Eisai Co Ltd 光学活性ヒダントイン誘導体
CA2020813C (en) * 1989-07-25 1995-08-01 Frederick Dana Cazer Nitrofurantoin crystals
US4966967A (en) * 1989-09-15 1990-10-30 Berlex Laboratories, Inc. 3,4,5,6-tetrahydro-2H-1,7,4-benzodioxazonines as cardiovascular agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US4994459A (en) * 1989-12-11 1991-02-19 American Home Products Corporation Aryloxypropane substituted piperazine derivatives with antiarrhythmic and antifibrillatory activity
US4963561A (en) * 1990-02-28 1990-10-16 Sterling Drug Inc. Imidazopyridines, their preparation and use
AU665209B2 (en) * 1991-08-14 1995-12-21 Procter & Gamble Pharmaceuticals Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents
DK0599968T3 (da) * 1991-08-14 2000-04-17 Procter & Gamble Pharma Oxazolidinonderivater, der er egnede som antiarytmi- og antifibrilleringsmidler

Also Published As

Publication number Publication date
NO992897L (no) 1994-02-14
DE69232681T2 (de) 2003-02-13
EP0598061B1 (en) 2002-07-17
US5462940A (en) 1995-10-31
DE69232681D1 (de) 2002-08-22
EP1231208A3 (en) 2003-12-10
CZ30694A3 (en) 1995-01-18
KR100295946B1 (ko) 2001-07-03
SK282656B6 (sk) 2002-11-06
IL102793A0 (en) 1993-01-31
PL170961B1 (en) 1997-02-28
ATE220675T1 (de) 2002-08-15
AU2471792A (en) 1993-03-16
PL170984B1 (pl) 1997-02-28
FI940657A0 (fi) 1994-02-11
PT100777B (pt) 1999-07-30
BR9206369A (pt) 1995-05-30
MY109205A (en) 1996-12-31
NO306676B1 (no) 1999-12-06
NZ243938A (en) 1996-10-28
HU221317B1 (en) 2002-09-28
HUT70152A (en) 1995-09-28
KR100273605B1 (ko) 2000-12-15
NO992899D0 (no) 1999-06-14
NO992898L (no) 1994-02-14
EP1231208A2 (en) 2002-08-14
EP0598061A1 (en) 1994-05-25
NO992899L (no) 1994-02-14
RU2221788C2 (ru) 2004-01-20
IL102793A (en) 1996-12-05
WO1993004061A1 (en) 1993-03-04
TW232691B (fi) 1994-10-21
NO992900D0 (no) 1999-06-14
AU668360B2 (en) 1996-05-02
JPH06509804A (ja) 1994-11-02
NO940497D0 (no) 1994-02-14
PT100777A (pt) 1993-12-31
NO992898D0 (no) 1999-06-14
DK0598061T3 (da) 2002-11-11
PH31451A (en) 1998-11-03
CA2115427C (en) 2000-05-02
NO992897D0 (no) 1999-06-14
NO940497L (no) 1994-02-14
FI109696B (fi) 2002-09-30
HK1048806A1 (zh) 2003-04-17
JP3040473B2 (ja) 2000-05-15
HU9400396D0 (en) 1994-05-30
NO310147B1 (no) 2001-05-28
CZ282368B6 (cs) 1997-07-16
ES2180537T3 (es) 2003-02-16
NO310148B1 (no) 2001-05-28
CA2115427A1 (en) 1993-03-04
NO310145B1 (no) 2001-05-28
MX9204730A (es) 1994-03-31
SK17194A3 (en) 1995-03-08
RU2130935C1 (ru) 1999-05-27
NO992900L (no) 1994-02-14
NO310146B1 (no) 2001-05-28

Similar Documents

Publication Publication Date Title
FI940657A0 (fi) Uusia 4-oksosyklisiä ureoita, jotka ovat käyttökelpoisia sydämen rytmihäiriöiden ja värinän vastaisina aineina
RU94015844A (ru) 4-оксоциклические соединения мочевины, пригодные для использования в качестве антиаритмических и антифибрилляционных средств, фармацевтическая композиция, способ лечения
DK0598046T3 (da) Hidtil ukendte urinstoffer egnede som antiarrytmi- og antifibrilleringsmidler
CA2115029A1 (en) Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents

Legal Events

Date Code Title Description
MA Patent expired